Antegrade Intestinal Fluid Reinfusion for Prevention of Low Anterior Resection Syndrome After Low Anterior Resection: a Single-Center, Prospective Randomized Controlled Trial.
- Sponsor
- Pei-Rong Ding
- Study ID
- NCT07537998
- Phase
- PHASE2/PHASE3
- Status
- Recruiting
Conditions
- Low Anterior Resection Syndrome
- Rectal Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- intestinal fluid infusion — COMBINATION_PRODUCTPrepare autologous intestinal fluid and perform rantegrade reinfusion from the distal end of the stoma.
- potable water — COMBINATION_PRODUCTInfuse potable water through the distal end of the stoma.
Study Details
The goal of this clinical trial is to learn if antegrade intestinal fluid reinfusion works to prevent low anterior resection syndrome (LARS) in patients with prophylactic ileal stoma. The main questions it aims to answer are: 1. Does it work to prevent LARS by antegrade intestinal fluid reinfusion before performing the ileostomy reversal surgery? 2. Is antegrade intestinal fluid reinfusion more effective than water infusion in preventing LARS. Participants will: 1. Receive either antegrade intestinal fluid reinfusion or antegrade water infusion through ileal stoma based on the standard of care at 1 month after anterior rectal resection, until the ileostomy reversal. 2. Keep a diary of their symptoms.
Key Dates
- First listed
- Apr 17, 2026
- Start date
- Apr 10, 2026
- Status verified
- Nov 2025
- Primary completion
- Apr 10, 2027
- Completion
- Apr 10, 2028
Study Design
- Enrollment
- 160 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Intestinal fluid reinfusionStarting from 4 weeks after the DIXON + ileostomy surgery until the day before the ileostomy reversal surgery, the patient was instructed on enema procedures by enterostomal therapist after being enrolled in the study. After preparing the autologous intestinal fluid, it is diluted with warm saline to a volume of 200-500 ml. It is then returned through the distal end of the ileal stoma in a retrograde manner, once every other day.
- Active Comparator: Water infusionStarting from 4 weeks after the DIXON + ileostomy surgery until the day before the ileostomy reversal surgery, the patient was instructed on enema procedures by enterostomal therapist after being enrolled in the study. Prepare 200-500 ml of potable water, and then infuse it antegradely from the distal end of the ileal stoma, once every other day.
Primary Outcome Measure
LARS score(m1) [ Time Frame: 1 month after ileostomy reversal surgery ]
Central Contacts
- Peirong Ding, M.D86-020-87343920
Find similar trials
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 PatientsPHASE1/PHASE2 · Recruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal CancerPHASE1/PHASE2 · Recruiting · Washington University School of Medicine · Boston, Massachusetts
- Exosomes in Rectal CancerRecruiting · University of Kansas Medical Center · Kansas City, Kansas